The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
|Articles|March 15, 2023
People and Business News — 3/23
The latest people and business news from the past month, all in one place.
Advertisement
People News
ProofPilot announced that its CEO Chris Venezia has been accepted into the Forbes Business Council.
HeartcoR Solutions has hired Michael Jandes as director of IT systems.
M3 Wake Research appointed Lucian Cappoli to serve as Head of Early Development and Phase I Operations.
Curavit announced its newest board member, Jackie Kent.
AutoCruitment, LLC appointed Eric Setzer as Chief Financial Officer and Kathy Twiddy appointed as General Counsel & Chief Compliance Officer.
uMotif announced that life science and healthcare executive Adam Deutsch has joined its Board of Directors.
Business News
Veeva Systems announced the increasing adoption of Veeva Vault EDC—including six of the top 20 pharma.
3H Medi Solution Inc. has selected THREAD to expand decentralized research capabilities and improve access to clinical research for patients in Japan.
Emmes announced the opening of a new office in Wilmington, North Carolina.
Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA quality standards.
Recognition
Curebase announced it has been named among Y Combinator's 2023 Top Private Companies, placing among the top 6% of all companies that appeared on the list.
Pharma Targeting is celebrating its 10-year anniversary in 2023.
Advertisement
Related to this article
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
In today’s ACT Brief, we examine why anti-kickback guidance and EHR-integrated trial matching must work together in community settings, why real-time trials depend on mature risk-based quality management, and how pharma is applying digital clones to predict outcomes.
The FDA’s RTCT initiative transmits predefined, clinically meaningful signals to regulators during active trials, so its value depends entirely on the maturity of sponsors’ upstream RBQM signal intelligence, KRIs, QTLs, and root-cause context, rather than on data speed.
In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated trial matching technology must work in tandem to reach representative patient populations at the community level.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
4
Real-Time Continuous Trials Through the Lens of Risk-Based Quality Management: Why RBQM Is the Infrastructure RTCT Cannot Exist Without
5